Back to Trades
Rubin Eyal
Chief Financial OfficerCIK 0001721411
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Rubin Eyal, Chief Financial Officer, has filed 2 SEC reports (2026), all concentrated in Nasus Pharma Ltd (NSRX), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Sep 21 | NSRX Nasus Pharma Ltd | Rubin Eyal | Chief Financial Officer | Other | $0 |
| Mar 27 | NSRX Nasus Pharma Ltd | Rubin Eyal | Chief Financial Officer | Other | $0 |
2 filings